跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Yesintek Concentrate for solution for infusion 130mg/26mL - HSA Drug Approval Details
Approvals
/
HSA
/
Yesintek Concentrate for solution for infusion 130mg/26mL
Approved
THERAPEUTIC
Yesintek Concentrate for solution for infusion 130mg/26mL
Biocon Biologics Limited (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 26, 2026
Approval ID
7da5742b3b20ef3c
Company
Biocon Biologics Limited (INDIA)
Type
Therapeutic
Approval Details
Approval Id
7da5742b3b20ef3c
Drug Name
Yesintek Concentrate for solution for infusion 130mg/26mL
Product Name
Yesintek Concentrate for solution for infusion 130mg/26mL
Approval Number
SIN17571P
Approval Date
2026-06-26
Registrant
CEDAR PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 26, 2026
Approval ID
7da5742b3b20ef3c
Type
Therapeutic
Back to HSA Approvals
